Skip to main content

Outset Medical, Inc.

OM
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001484612

In the last 90 days, Outset Medical, Inc. insiders filed 1 open-market purchase and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $59.9M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 17, 2026
$59.6M
Insider buysLast 90 days, $870.3K in total
1
Insider sellsLast 90 days, $29.0K in total
2
13F holdersQ2 2026, −4 vs. previous quarter
93
13F valueReported value at the end of Q2 2026
$59.9M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$119.5M
+5.1% year over year
Net income, FY2025
-$81.7M
No comparable prior period
Free cash flow, FY2025
-$47.1M
No comparable prior period
Revenue, Q3 FY2026
$33.6M
+14.2% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $81.7M (68.3% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
812.8K
Shares sold short
Change
−119.8K
−12.9% vs. previous
Days to cover
8.61
At average daily volume

Superinvestors holding OM, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding OM at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Outset Medical, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2026 (view filing)7:31 PM ETNov 161 dayGaeta ReneeChief Financial OfficerSSale−4.50K$3.67−$16.5K−2.5%176.3K after
Nov 17, 2026 (view filing)7:28 PM ETNov 161 dayTrigg LeslieChair and CEOSSale−3.40K$3.67−$12.5K−1.7%191.2K after
Oct 5, 2026 (view filing)7:24 PM ETOct 1-24 daysLeonard Braden Michael10% OwnerPPurchase+244.9K$3.55+$870.3K+9.7%2.76M after2 lots
Aug 18, 2026 (view filing)7:45 PM ETAug 171 dayTrigg LeslieChair and CEOSSale−3.44K$4.39−$15.1K−1.7%194.6K after
Aug 18, 2026 (view filing)6:51 PM ETAug 171 dayBrottem John L.General CounselSSale−2.63K$4.39−$11.6K−2.9%87.5K after
Aug 18, 2026 (view filing)6:46 PM ETAug 171 dayGaeta ReneeChief Financial OfficerSSale−4.54K$4.39−$19.9K−2.5%180.8K after
Jun 5, 2026 (view filing)Jun 32 daysGaeta ReneeChief Financial OfficerSSale−17.7K$4.94−$87.3K−13.4%113.8K after
May 19, 2026 (view filing)May 154 daysTrigg LeslieChair and CEOSSale−3.44K$3.70−$12.7K−3.4%98.9K after
May 19, 2026 (view filing)May 154 daysNash MarcEVP Operations R&D & ServiceSSale−1.58K$3.70−$5.85K−4.0%38.4K after
May 19, 2026 (view filing)May 154 daysBrottem John L.General CounselSSale−2.64K$3.70−$9.76K−8.0%30.3K after

Top 10 13F holders, Q2 2026

See all 93 holders

The largest institutional positions in Outset Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding OM in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC2,742,887$11.8M0.00%+1,2140.0%Added
BML Capital Management, LLC2,519,701$10.9M6.22%+617,500+32.5%Added
AQR Capital Management LLC998,961$4.32M0.00%+190,676+23.6%Added
Perceptive Advisors LLC833,333$3.60M0.06%00.0%Unchanged
Vanguard Capital Management LLC780,134$3.37M0.00%+16,312+2.1%Added
Bank of America Corp665,847$2.88M0.00%−283,550−29.9%Reduced
PFM Health Sciences, LP582,122$2.51M0.22%−12,508−2.1%Reduced
Ensign Peak Advisors, Inc434,341$1.88M0.00%−92,244−17.5%Reduced
BlackRock, Inc.418,211$1.81M0.00%−845,008−66.9%Reduced
Assenagon Asset Management S.A.339,438$1.47M0.00%−164,655−32.7%Reduced

Holders of 5% or more of OM

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Outset Medical, Inc..

Largest holders of OM from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BML Investment Partners, L.P.13G/A14.70%2.76M shares+1.10 ppfrom 13.60%Jan 14, 20265 filingsOct 6, 2026SEC
FMR LLC13G/A14.50%2.60M shares+7.50 ppfrom 7.00%Feb 8, 20217 filingsApr 7, 2025SEC
Perceptive Advisors LLC13G9.50%5.63M shares–Feb 16, 20213 filingsFeb 28, 2025SEC
Perceptive Advisors LLC13G/A6.70%1.21M shares–May 15, 20251 filingMay 15, 2025SEC